InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Net Cash Flow (2016 - 2026)

InflaRx's (IFRX) quarterly Net Cash Flow came in at $237.3 million in Q2 2026, up 743.98% year-over-year from $28.1 million in Q2 2025, and up 366.94% quarter-over-quarter from -$88.9 million in Q1 2026.

Analysis

InflaRx (IFRX) Net Cash Flow (2016 - 2026) Analysis & Trends

InflaRx has disclosed Net Cash Flow across 11 years of filings, most recently posting $237.3 million for Q2 2026.

  • In Q2 2026, Net Cash Flow rose 743.98% year-over-year to $237.3 million; the TTM figure through Jun 2026 stood at $152.1 million (down 22.88% YoY), while the FY2025 annual figure was $1.4 million, down 68.86% from the prior year.
  • Net Cash Flow came in at $237.3 million for Q2 2026 at InflaRx, up from -$88.9 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $299.8 million in Q4 2024 to a low of -$125.5 million in Q2 2022.
  • Average Net Cash Flow over 5 years is $6.6 million, with a median of -$11.2 million recorded in 2023.
  • Year-over-year, Net Cash Flow slumped 19478.78% in 2022 and soared 3521.77% in 2024.
  • Over 5 years, Net Cash Flow stood at $277.1 million in 2022, then plunged by 103.16% to -$8.8 million in 2023, then soared by 3521.77% to $299.8 million in 2024, then tumbled by 96.25% to $11.3 million in 2025, then surged by 2009.35% to $237.3 million in 2026.
  • Per Business Quant data, the three most recent Net Cash Flow figures were $237.3 million in Q2 2026, -$88.9 million in Q1 2026, and $11.3 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -4.43 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 652.90 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -504.30 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -183.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -496,000.00
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -2.09 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -170.75 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn 237.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 237.34 Mn
Mar 31, 2026 -88.91 Mn
Dec 31, 2025 11.25 Mn
Sep 30, 2025 -7.62 Mn
Jun 30, 2025 -36.86 Mn
Mar 31, 2025 32.24 Mn
Dec 31, 2024 299.84 Mn
Sep 30, 2024 -98.05 Mn
Jun 30, 2024 -122.21 Mn
Mar 31, 2024 -79.99 Mn
Dec 31, 2023 -8.76 Mn
Sep 30, 2023 2.20 Mn
Jun 30, 2023 -13.61 Mn
Mar 31, 2023 17.28 Mn
Dec 31, 2022 277.12 Mn
Sep 30, 2022 -89.99 Mn
Jun 30, 2022 -125.52 Mn
Mar 31, 2022 -86.63 Mn
Dec 31, 2021 -51.97 Mn
Sep 30, 2021 -459,611.90